Propanc Biopharma, Inc. (PPCB)

NASDAQ: PPCB · Real-Time Price · USD

0.1916

-0.0111 (-5.48%)

At close: Feb 20, 2026, 4:00 PM EST

0.1901

-0.0015 (-0.78%)

After-hours: Feb 20, 2026, 7:50 PM EST

Propanc Biopharma Cash Flow Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Net Income	-66.07	-58.92	-1.82	-2.66	-2.66	-2.03
Depreciation & Amortization	0.02	0.02	0.02	0.02	0.01	0
Other Amortization	0.36	0.3	0.29	0.2	0.05	0.14
Stock-Based Compensation	62.18	55.97	-	0.14	0.39	0.21
Other Operating Activities	0.23	1.09	0.15	0.72	0.61	0.09
Change in Accounts Payable	-0.23	0.19	0.24	0.08	0.02	0.18
Change in Other Net Operating Assets	0.37	0.95	0.18	0.39	0.15	0.26
Operating Cash Flow	-3.13	-0.41	-0.94	-1.11	-1.44	-1.15
Capital Expenditures	-0	-	-	-	-	-
Investing Cash Flow	-0	-	-	-	-	-
Short-Term Debt Issued	-	0.54	0.84	0.59	0.77	0.33
Long-Term Debt Issued	-	0.34	0.22	-	-	-
Total Debt Issued	0.75	0.89	1.06	0.59	0.77	0.33
Short-Term Debt Repaid	-	-0.13	-0.14	-	-	-0.04
Total Debt Repaid	-1.06	-0.13	-0.14	-	-	-0.04
Net Debt Issued (Repaid)	-0.31	0.76	0.92	0.59	0.77	0.28
Issuance of Common Stock	3.31	-	0.02	0.52	0.72	0.78
Other Financing Activities	-0.24	-0.26	-	-	-	-
Financing Cash Flow	3.71	0.49	0.94	1.11	1.49	1.06
Foreign Exchange Rate Adjustments	-0.03	-0.09	0	-0	-0.05	0.02
Net Cash Flow	0.55	-0.01	0.01	0.01	0	-0.06
Free Cash Flow	-3.13	-0.41	-0.94	-1.11	-1.44	-1.15
Free Cash Flow Per Share	-0.30	-0.10	-	-	-	-
Cash Interest Paid	0.13	0.03	0.01	0	0	0.01
Levered Free Cash Flow	14.25	12.9	-0.78	-0.51	-1.5	-0.77
Unlevered Free Cash Flow	14.35	12.95	-0.66	-0.38	-1.19	-0.63
Change in Working Capital	0.15	1.14	0.42	0.47	0.17	0.44

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.